Atlantic Salmon Trial Successfully Demonstrates Efficacy of Novel Alternative Protein for Aquafeed

A new milestone paves way for SYLFEED as its Atlantic Salmon trials successfully demonstrate efficacy of novel protein for aqua feed.

The juvenile Atlantic salmon study was conducted by Matis Icelandic Food & Biotech R&D as part of the SYLFEED project, and it was designed to demonstrate the nutritional performance of Arbiom’s protein product (SylPro®) compared to conventional plant and animal protein sources.

“These findings indicate that SylPro can be used to replace fish meal or plant-based proteins in feed for juvenile Atlantic salmon, a crucial developmental stage, and deliver equivalent nutritional performance as conventional protein sources up to 20 percent inclusion level,” said Alexandra Leeper, PhD candidate from Matis.

TENGILIÐUR / CONTACT

    Arbiom and partners in the SYLFEED consortium are continuing to validate the nutritional performance and sustainability of SylPro as a new source of protein produced from wood.